News
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
ProBio, a global leader in the antibody discovery and development, is pleased to announce its upcoming poster presentation at the American Association for Cancer Research? (AACR) 116th Annual Meeting, ...
In the short term, the U.S. government must move urgently to shore up supply-chain vulnerabilities in critical drug categories - starting with antibiotics. Amoxicillin, a drug that is hard to find in ...
Heparin is cheap and essential to millions of hospitalized people. Tariffs could disrupt the supply chain that gets ...
Bayer’s Pharmaceutical Company will soon unveil a major expansion project at its Central Pennsylvania manufacturing facility, ...
Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new ...
Benchmark S&P 500 falls more than 1.5 percent after Trump says import taxes on China will rise to 104 percent.
Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived ...
China vows to hit back at Trump’s tariffs which total 54pc; pharmaceuticals, semiconductors and gold have been excluded but ...
11d
HotCopper on MSNCSL survives a brutal sell-off but dips on US tariff response as investors eye pharma riskCSL Ltd (ASX:CSL) has seen shares fall nearly half a percent in afternoon trades on Thursday as the company responds to Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results